Glutamate Receptor Antagonists Protect from Virus-induced Neural Degeneration

Annals of Neurology

Volumn 55, Issue 4, 2004, Pages 541-549

  Nargi Aizenman, Jennifer L ^a,c   Havert, Michael B ^a   Zhang, Ming ^a   Irani, David N ^a,b   Rothstein, Jeffrey D ^b   Griffin, Diane E ^a,b  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Howard Hughes Medical Institute Cold Spring Harbor Laboratory Cold Spring Harbor   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 (4 AMINOPHENYL) 4 METHYL 7,8 METHYLENEDIOXY 5H 2,3 BENZODIAZEPINE; AMPA RECEPTOR ANTAGONIST; DIZOCILPINE; GLUTAMATE RECEPTOR ANTAGONIST; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIVIRAL ACTIVITY; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DEATH; DRUG EFFECT; DRUG SCREENING; ENCEPHALOMYELITIS; EVIDENCE BASED MEDICINE; FEMALE; MOUSE; NERVE CELL DEGENERATION; NERVE CELL NECROSIS; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PARALYSIS; PRIORITY JOURNAL; SINDBIS VIRUS; SPINAL CORD MOTONEURON; VIRUS INFECTION; VIRUS REPLICATION;

ALPHAVIRUS INFECTIONS; ANIMALS; BRAIN; ENCEPHALITIS, VIRAL; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; MICE; MICE, INBRED C57BL; NERVE DEGENERATION; RECEPTORS, GLUTAMATE; SINDBIS VIRUS; SPINAL CORD;

EID: 1642305906     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.20033     Document Type: Article

References (61)

1. Center for Disease Control. Acute flaccid paralysis syndrome associated with West Nile virus infection - Mississippi and Louisiana, July-August 2002. MMWR 2002;51:825-828.
2. Strauss JH, Strauss EG. The alphaviruses: gene expression, replication and evolution. Microbiol Rev 1994;58:491-562.
3. Griffin DE. Alphavirus pathogenesis and immunity. In: Schlesinger S, Schlesinger MJ, eds. The togaviridae and flaviviridae. New York: Plenum, 1986:209-249.
4. Okada T, Yamada N, Kakegawa W, et al. Sindbis viral-mediated expression of Ca2+-permeable AMPA receptors at hippocampal CA1 synapses and induction of NMDA receptor-independent long-term potentiation. Eur J Neurosci 2001;13: 1635-1643.
5. Griffin DE, Johnson RT. Role of the immune response in recovery from Sindbis virus encephalitis in mice. J Immunol 1977;118:1070-1075.
6. Jackson AC, Moench TR, Griffin DE. The pathogenesis of spinal cord involvement in the encephalomyelitis of mice caused by neuroadapted Sindbis virus infection. Lab Invest 1987;56: 418-423.
7. Jackson AC, Moench TR, Trapp BD, et al. Basis of neurovirulence in Sindbis virus encephalomyelitis of mice. Lab Invest 1988;58:503-509.
8. Olney J. Brain lesions, obesity, and other disturbances in mice treated with monosodium glutamate. Science 1969;164: 719-721.
9. Choi D, Maulucci-Gedde M, Kriegstein A. Glutamate neurotoxicity in cortical cell culture. J Neurosci 1987;7:357-368.
10. Lee J, Zipfel G, Cho D. The changing landscape of ischaemic brain injury mechanisms. Nature 1999;399:A7-A14.
11. Nicotera P, Orrenius S. The role of calcium in apoptosis. Cell Calcium 1998;23:173-180.
12. Choi D, Koh J, Peters S. Pharmacology of glutamate neurotoxicity in cortical cell culture: attenuation by NMDA antagonists. J Neurosci 1998;8:185-196.
13. Gorter J, Petrozzino J, Aronica E, et al. Global ischemia induces downregulation of Glur2 mRNA and increases AMPA receptor-mediated Ca2+ influx in hippocampal CA1 neurons of gerbil. J Neurosci 1997;17:6179-6188.
14. Nellgard B, Wieloch T. Postischemic blockade of AMPA but not NMDA receptors mitigates neuronal damage in the rat brain following transient severe cerebral ischemia. J Cereb Blood Flow Metab 1992;12:2-11.
15. Sherdown M, Suzdak P, Nordholm L. AMPA, but not NMDA, receptor antagonism is neuroprotective in gerbil global ischaemia, even when delayed 24 h. Eur J Pharmacol 1993;236: 347-353.
16. Buchan A, Li H, Cho S, et al. Blockade of the AMPA receptor prevents CA1 hippocampal injury following severe but transient forebrain ischemia in adult rats. Neurosci Lett 1991;132: 255-258.
17. Xue D, Huang Z, Barnes K, et al. Delayed treatment with AMPA, but not NMDA, antagonists reduces neocortical infarction. J Cereb Blood Flow Metab 1994;14:251-261.
18. Gill R, Lodge D. Pharmacology of AMPA antagonists and their role in neuroprotection. Int Rev Neurobiol 1997;40:197-232.
19. 2+ permeable AMPA or kainate receptors: possible key factors in selective neurodegeneration. Trends Neurosci 2000;23:365-371.
20. McDonald J, Althomsons S, Hyre K, et al. Oligodendrocytes from forebrain are highly vulnerable to AMPA/kainate receptor-mediated excitotoxicity. Nat Med 1998;4:291-297.
21. Matute C, Sanchez-Gomez M, Martinez-Millan L, et al. Glutamate receptor-mediated toxicity in optic nerve oligodendrocytes. Proc Natl Acad Sci USA 1997;94:8830-8835.
22. Rothstein J, Jin L, Dykes-Hoberg M, et al. Chronic inhibition of glutamate uptake produces a model of slow neurotoxicity. Neurobiology 1993;90:6591-6595.
23. Bar-Peled O, O'Brien R, Morrison J, et al. Cultured motor neurons possess calcium-permeable AMPA/kainate receptors. Neuroreport 1999;10:855-859.
24. Williams T, Day N, Ince P, et al. Calcium-permeable alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptors: a molecular determinant of selective vulnerability in amyotrophic lateral sclerosis. Ann Neurol 1997;42:200-207.
25. Nargi-Aizenman J, Griffin D. Sindbis virus-induced neuronal death is both necrotic and apoptotic and is ameliorated by N-methyl-D-aspartate receptor antagonists. J Virol 2001;75: 7114-7121.
26. Nadler J, Perry B, Cotman C. Intraventricular kainic acid preferentially destroys hippocampal pyramidal cells. Nature 1978; 271:676-677.
27. Olney J, Fuller T, de Gubareff T. Acute dendrotoxic changes in the hippocampus of kainate treated rats. Brain Res 1979;176: 91-100.
28. Lewis J, Wesselingh SL, Griffin DE, et al. Alphavirus-induced apoptosis in mouse brains correlates with neurovirulence. J Virol 1996;70:1828-1835.
29. Kimura T, Griffin D. Extensive immune-mediated hippocampal damage in mice surviving infection with neuroadapted Sindbis virus. Virology 2003;311:28-39.
30. Havert M, Schofield B, Griffin D, et al. Activation of divergent neuronal cell death pathways in different target cell populations during neuroadapted Sindbis virus infection of mice. J Virol 2000;74:5352-5356.
31. + T cells and major histocompatibility complex class I expression in the central nervous system of mice infected with neurovirulent Sindbis virus. J Virol 2000;74:6117-6125.
32. Andersson T, Schwarcz R, Love A, et al. Measles virus-induced hippocampal neurodegeneration in the mouse: a novel, subacute model for testing neuroprotective agents. Neurosci Let 1993;154:109-112.
33. Szabados T, Gigler G, Gacsalyi I, et al. Comparison of anticonvulsive and acute neuroprotective activity of three 2,3-benzodiazepine compounds, GYKI 52466, GYKI 53405, and GYKI 53655. Brain Res Bull 2001;55:387-391.
34. Yamamoto T, Hirano A. A comparative study of modified Bielschowsky, Bodian and thioflavin S stains of Alzheimer's neurofibrillary tangles. Neuropathol Appl Neurobiol 1986;12: 3-9.
35. Stanley J, Cooper SJ, Griffin DE. Alphavirus neurovirulence: monoclonal antibodies discriminating wild-type from neuroadapted Sindbis virus. J Virol 1985;56:110-119.
36. Hsu SM, Raine L, Fanger H. The use of avidin-biotin-peroxidase-complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981;29:577-580.
37. Wozniak D, Olney J, Kettinger L III, et al. Behavioral effects of MK-801 in the rat. Psychopharmacology 1990;101:47-56.
38. Olney J, Ikonomidou C, Mosinger J, et al. MK-801 prevents hypobaric-ischemic neuronal degeneration in infant rat brain. J Neurosci 1989;9:1701-1704.
39. Tarnawa I, Farkas S, Berzsenyi P, et al. Electrophysiological studies with a 2,3-benzodiazepine muscle relaxant: GYKI 52466. Eur J Pharmacol 1989;167:193-199.
40. Chapman A, Smith S, Meldrum B. The anticonvulsant effect of the non-NMDA antagonists, NBQX and GYKI 52466, in mice. Epilepsy Res 1991;9:92-96.
41. Levine B, Hardwick JM, Trapp BD, et al. Antibody-mediated clearance of alphavirus infection from neurons. Science 1991; 254:856-860.
42. Lipton SA. Requirement for macrophages in neuronal injury induced by HIV envelope protein gp120. Neuroreport 1992;3: 913-915.
43. Lipton SA, Sucher NJ, Kaiser PK, et al. Synergistic effects of HIV coat protein and NMDA receptor-mediated neurotoxicity. Neuron 1991;7:111-118.
44. Lipton SA. Models of neuronal injury in AIDS: another role for the NMDA receptor. Trends Neurosci 1992;15:75-79.
45. Toggas SM, Masliah E, Rockenstein EM, et al. Central nervous system damage produced by expression of the HIV-1 coat protein gp120 in transgenic mice. Nature 1994;367:188-193.
46. Toggas S, Masliah E, Mucke L. Prevention of HIV-1 gp120-induced neuronal damage in the central nervous system of transgenic mice by the NMDA receptor antagonist memantine. Brain Res 1996;706:303-307.
47. Giulian D, Vaca K, Noonan CA. Secretion of neurotoxins by mononuclear phagocytes infected with HIV-1. Science 1990; 250:1593-1596.
48. Giulian D, Wendt E, Vaca K, et al. The envelope glycoprotein of human immunodeficiency virus type 1 stimulates release of neurotoxins from monocytes. Proc Natl Acad Sci USA 1993; 90:2769-2773.
49. Gruol D, Yu N, Parsons K, et al. Neurotoxic effects of feline immunodeficiency virus, FIV-PPR. J Neurovirol 1998;4: 415-425.
50. Starling I, Wright A, Arbuthnott G, et al. Acute in vivo neurotoxicity of peptides from Maedi Visna virus transactivating protein Tat. Brain Res 1999;830:285-291.
51. Ulug ET, Waite MRF, Bose HR Jr. Alterations in monovalent cation transport in Sindbis virus-induced chick cells. Virology 1984;132:118-130.
52. Ulug ET, Garry RF, Bose HR Jr. The role of monovalent cation transport in Sindbis virus maturation and release. Virology 1989;172:42-50.
53. Bashford CL, Alder GM, Gray MA, et al. Oxonol dyes as monitors of membrane potential: the effect of viruses and toxins on the plasma membrane potential of animal cells in monolayer culture and in suspension. J Cell Physiol 1985;123:326-336.
54. Szatkowski M, Attwell D. Triggering and execution of neuronal death in brain ischaemia: two phases of glutamate release by different mechanisms. Trends Neurosci 1994;17:359-365.
55. Li S, Stys PK. Na(+)-K(+)-ATPase inhibition and depolarization induce glutamate release via reverse Na(+)-dependent transport in spinal cord white matter. Neuroscience 2001;107: 675-683.
56. Piani D, Frei K, Do K, et al. Murine brain macrophages induced NMDA receptor mediated neurotoxicity in vitro by secreting glutamate. Neurosci Lett 1991;133:159-162.
57. Malipiero J, Heuss C, Schlapbach R, et al. Involvement of the N-methyl-D-aspartate receptor in neuronal cell death induced by cytotoxic T cell-derived secretory granules. Eur J Immunol 1999;29:3053-3062.
58. Piani D, Spranger M, Frei K, et al. Macrophage-induced cytotoxicity of N-methyl-D-aspartate receptor positive neurons involves excitatory amino acids rather than reactive oxygen intermediates and cytokines. Eur J Immunol 1992;22:2429-2436.
59. Ankarcrona M, Dypbukt J, Bonfoco E, et al. Glutamate-induced neuronal death: a succession of necrosis or apoptosis depending on mitochondrial function. Neuron 1995;15: 961-973.
60. Virgo L, Samarasinghe S, de Belleroche J. Analysis of AMPA receptor subunit mRNA expression in control and ALS spinal cord. Neuroreport 1996;7:2507-2511.
61. Herzbert U, Murtaugh M, Carroll D, et al. Spinal cord NMDA receptors modulate peripheral immune responses and spinal cord c-fos expression after immune challenge in rats subjected to unilateral mononeuropathy. J Neurosci 1996;16:730-743.